SCHEMBL1591782

SCHEMBL1591782

O=S(=O)(NC1CC(O)c2ccccc21)c1c(Br)nc2n1CCS2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.36
MAPT P10636 4/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP2C19 P33261 2/20 0.33
ALDH1A1 P00352 1/20 0.33
USP2 O75604 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TNKS2 Q9H2K2 3/20 0.33
TDP1 Q9NUW8 2/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
CYP1A2 P05177 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591157 0.88 HTR6 (0.49) HTR6MAPTMEN1KMT2ACYP2C19
SCHEMBL1590232 0.81 HTR6 (0.35) HTR6MAPTMEN1KMT2ACYP2C19
SCHEMBL1422191 0.76 ACLY (0.39) HTR6SMN1; SMN2POLB
SCHEMBL1590394 0.74 HTR6 (0.46) HTR6MEN1KMT2AUSP2KDM4E
Hydrochloric Acid SCHEMBL1590700 0.74 HTR6 (0.36) HTR6MEN1KMT2AALDH1A1GAA
SCHEMBL1591023 0.70 HTR6 (0.50) HTR6MAPTMEN1KMT2AALDH1A1
SCHEMBL1590549 0.69 HTR6 (0.47) HTR6ALDH1A1USP2TNKS2MAPK1
SCHEMBL1422160 0.69 ACLY (0.52) HTR6
Hydrochloric Acid SCHEMBL1590417 0.69 HTR6 (0.46) HTR6USP2TNKS2MAPK1TNKS
SCHEMBL1590351 0.67 HTR6 (0.69) HTR6MAPTMEN1KMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324035-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-05-25 EP claimed
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-04-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS HTR6, HTR2A, HTR4 HTR6 1/4885MAPT 1860/4885MEN1 3303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.